Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A 54-year-old male patient with obesity and recalcitrant psoriasis previously trialed etanercept, efalizumab, narrowband UVB, psoralen-UVA, ciclosporin, methotrexate, acitretin, and fumaric acid without response
For example, its combination with thymoquinone induces extensive tumor necrosis, increases apoptosis, suppresses angiogenesis, and activates a T helper 1 (TH1) immune response, resulting in significant tumor size reduction and improved cure rates without liver toxicity 166
Abed OA, Attlassy Y, Xu J, Han K, Moon JJ
(PubMed) Bonvicini M, Travaglini S, Lelli D, Antonelli Incalzi R, Pedone C
US$ 24.46
US$ 24.94
US$ 29.67
US$ 29.93
US$ 24.61
US$ 25.88
